Jiyun Lee, M.D., Seok Whan Moon, M.D., Ph.D., Jung Suk Choi, M.D., Kwanyong Hyun, M.D., Young Kyu Moon, M.D., Ph.D., Mi Hyoung Moon, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2020;53:93-103. https://doi.org/10.5090/kjtcs.2020.53.3.93

June Lee, Ji Yun Lee, Jung Suk Choi, Sook Whan Sung. Korean J Thorac Cardiovasc Surg 2019;52:141-7. https://doi.org/10.5090/kjtcs.2019.52.3.141

Accurate intraoperative assessment of mediastinal lymph nodes is a critical aspect of lung cancer surgery. The efficacy and potential for upstaging implicit in these dissections must therefore be revisited in the current era of uniportal video-assisted thoracoscopic surgery (VATS). A retrospective study was conducted in which 544 patients with stage I (T1abc-T2a, N0, M0) primary lung cancer were analyzed. To assess risk factors for nodal upstaging and to limit any imbalance imposed by surgical choices, we constructed an inverse probability of treatment-weighted (IPTW) logistic regression model (in addition to non-weighted logistic models). We also evaluated risk factors for early locoregional recurrence using IPTW logistic regression analysis. In the comparison of uniportal and multiportal VATS, the resected lymph node count (14.03±8.02 vs. 14.41±7.41, respectively; p=0.48) and rate of nodal upstaging (6.5% vs. 8.7%, respectively; p=0.51) appeared similar. Predictors of nodal upstaging included tumor size (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.12-2.70), carcinoembryonic antigen level (OR, 1.11; 95% CI, 1.04-1.18), and histologically confirmed pleural invasion (OR, 3.97; 95% CI, 1.89-8.34). The risk factors for locoregional recurrence within 1 year were found to be number of resected N2 nodes, age, and nodal upstaging. Uniportal and multiportal VATS appear similar with regard to accuracy and thoroughness, showing no significant difference in the extent of nodal dissection.

Original Article Risk factors and age-specific monthly patterns of primary spontaneous pneumothorax: a multicenter study Seung Keun Yoon, Hee Kyung Kim, Jiyun Lee, Young-Du Kim, Deog Gon Cho

Pulmonary sarcomatoid carcinoma is a rare and highly aggressive variant of non-small cell lung cancer with consistently poor outcomes. While recent evidenc

Hye Rim Na, M.D., Jong Hui Suh, M.D., Ph.D., Jiyun Lee, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.139